Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington's disease (Enroll-HD). (2020)

First Author: Harris KL
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jnnp-2019-322038

PubMed Identifier: 32229581

Publication URI: http://europepmc.org/abstract/MED/32229581

Type: Journal Article/Review

Volume: 91

Parent Publication: Journal of neurology, neurosurgery, and psychiatry

Issue: 6

ISSN: 0022-3050